We are live on
!
Find out more
CAM
Congress Asset Management Portfolio holdings
AUM
$16.3B
1-Year Est. Return
42.69%
This Fund
S&P 500
This Quarter
Est. Return
+9.74%
1 Year Est. Return
+42.69%
3 Year Est. Return
+133.81%
5 Year Est. Return
+171.24%
10 Year Est. Return
+841.07%
AUM
$11.5B
AUM Growth
+$780M
(+7.3%)
Cap. Flow
-$39.7M
Cap. Flow
% of AUM
-0.34%
Top 10 Holdings %
Top 10 Hldgs %
16.02%
Holding
391
New
23
Increased
185
Reduced
140
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Factset
FDS
|
+$106M |
| 2 |
Bruker
BRKR
|
+$98.1M |
| 3 |
HOLX
Hologic
HOLX
|
+$97.4M |
| 4 |
Martin Marietta Materials
MLM
|
+$69M |
| 5 |
Moody's
MCO
|
+$58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Masco
MAS
|
+$103M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$89.3M |
| 3 |
Trimble
TRMB
|
+$81.1M |
| 4 |
Dover
DOV
|
+$79M |
| 5 |
Ciena
CIEN
|
+$60.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.8% |
| 2 | Healthcare | 17.55% |
| 3 | Consumer Discretionary | 15.17% |
| 4 | Industrials | 15.09% |
| 5 | Consumer Staples | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
301
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.2M | 0.01% |
11,645
-47,778
| -80% | -$5.04M |
|
302
Texas Roadhouse
TXRH
$13.8B
| $1.12M | 0.01% |
9,960
-2,684
| -21% | -$295K |
|
|
ZYXI
303
DELISTED
Zynex
ZYXI
| $1.12M | 0.01% |
116,576
+1,449
| +1% | +$15K |
|
|
ALE
304
DELISTED
Allete
ALE
| $1.05M | 0.01% |
18,137
+233
| +1% | +$14.4K |
|
305
Salesforce
CRM
$157B
| $1.04M | 0.01% |
4,916
-585
| -11% | -$119K |
|
306
Kymera Therapeutics
KYMR
$8.66B
| $1.04M | 0.01% |
45,125
+556
| +1% | +$15.9K |
|
307
Automatic Data Processing
ADP
$107B
| $1.03M | 0.01% |
4,700
| – | – |
|
308
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.89B
| $953K | 0.01% |
38,133
+461
| +1% | +$12.1K |
|
|
BDN
309
Brandywine Realty Trust
BDN
$546M
| $931K | 0.01% |
200,114
+2,001
| +1% | +$8.16K |
|
310
Becton Dickinson
BDX
$46.5B
| $928K | 0.01% |
3,515
+409
| +13% | +$104K |
|
311
Union Pacific
UNP
$176B
| $893K | 0.01% |
4,366
-48,392
| -92% | -$9.62M |
|
312
Byrna Technologies
BYRN
$106M
| $838K | 0.01% |
167,252
| – | – |
|
313
Lamb Weston
LW
$7.32B
| $832K | 0.01% |
7,240
| – | – |
|
314
Arthur J. Gallagher & Co
AJG
$64.3B
| $818K | 0.01% |
3,725
+8
| +0.2% | +$1.67K |
|
315
Berkshire Hathaway Class B
BRK.B
$1.11T
| $800K | 0.01% |
2,345
| – | – |
|
|
ACLX
316
DELISTED
Arcellx
ACLX
| $792K | 0.01% |
+25,045
| New | +$957K |
|
317
Progressive
PGR
$123B
| $768K | 0.01% |
5,802
-37
| -0.6% | -$4.96K |
|
318
Editas Medicine
EDIT
$434M
| $742K | 0.01% |
90,114
+565
| +0.6% | +$4.92K |
|
319
IQVIA
IQV
$39B
| $709K | 0.01% |
3,156
-2,861
| -48% | -$574K |
|
320
Simon Property Group
SPG
$72.7B
| $702K | 0.01% |
6,080
-68,533
| -92% | -$7.46M |
|
321
Highwoods Properties
HIW
$3.56B
| $652K | 0.01% |
27,256
+337
| +1% | +$7.46K |
|
322
Verizon
VZ
$190B
| $642K | 0.01% |
17,256
-243,080
| -93% | -$9M |
|
|
CSW
323
CSW Industrials
CSW
$5.63B
| $610K | 0.01% |
3,671
-4
| -0.1% | -$578 |
|
324
Marriott International
MAR
$93.4B
| $602K | 0.01% |
3,277
| – | – |
|
325
Vanguard S&P 500 ETF
VOO
$1.01T
| $592K | 0.01% |
1,454
| – | – |
|
Similar funds
UCFA
LCOV
CCMG
IG
EIP
CI
AIMCA
Congress Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Congress Asset Management held 391 positions worth $11.5B, up 7.3% from $10.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Congress Asset Management's Q2 2023 filing shows 23 new, 185 increased, 140 reduced and 18 closed positions. Its largest new stake was Factset: 263,630 shares worth $106M. The largest sale was Masco, an estimated $103M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Congress Asset Management's largest Q2 2023 buy was Factset: 263,630 shares worth $106M.
- Congress Asset Management added most to Martin Marietta Materials in Q2 2023, an estimated $69M increase.
- Congress Asset Management's biggest Q2 2023 reduction was Neurocrine Biosciences, cutting an estimated $89.3M.
- Congress Asset Management fully exited Masco in Q2 2023, selling an estimated $103M.
- Congress Asset Management's ten largest holdings make up 16% of its $11.5B portfolio in Q2 2023.
- Congress Asset Management opened 23 new positions and closed 18 in Q2 2023.
- Congress Asset Management's portfolio value rose 7.3% quarter-over-quarter to $11.5B.
Based on Congress Asset Management's 13F filing for Q2 2023, filed 27 Jul 2023.